GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Lenvatinib mesylate is under clinical development by Eisai and currently in Phase I for Fallopian Tube Cancer.

How should we interpret recent findings about the possible role of the fallopian tubes in ovarian cancer? Robert DeBernardo, MD, gynecologic oncologist at Cleveland Clinic, gives us his take Share ...

A phase 1 trial evaluating FSHR-targeting CAR T cells for patients with ovarian cancer has dosed the first patient in its ...

Epithelial ovarian cancer is the most common type of ovarian cancer. Primary peritoneal cancer and fallopian tube cancer are similar to epithelial ovarian cancer and are treated in the same way. Germ ...

endometrioid adenocarcinoma of the fallopian tube. This patient had a strong family history of breast and ovarian cancers, and genetic study suggested a lifetime risk of breast cancer of about 80% ...

Discover crucial early warning signs of ovarian cancer that may surface during or after meals. Learn about symptoms, risk ...

Ovarian cancer is when abnormal cells in the ovary, fallopian tube or peritoneum begin to grow and divide in an uncontrolled way. They eventually form a growth (tumour). If not caught early, cancer ...

Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation (CDE) of the National ...